The ITA notifies Brazilian rider Rodolpho Riskalla of an apparent anti-doping rule violation

The ITA reports that a sample collected during an in-competition testing mission in the scope of the Para Grand Prix Freestyle – Grade IV Al Shaqab, held in Doha, Qatar, on 25 February 2023 from Rodolpho Riskalla, a rider from Brazil, has returned an Adverse Analytical Finding (AAF) for the prohibited substance “SARMS LGD-4033 (ligandrol)”.

SARMS LGD-4033 (ligandrol) is prohibited under the 2023 WADA Prohibited list as anabolic agent (S1.2). It is prohibited at all times and considering that it is a non-specified substance a provisional suspension is mandatory under the FEI Anti-Doping Rules for human athletes.

The athlete has been informed of the case and has been provisionally suspended until the resolution of the matter. He has the right to request the analysis of the B-sample.

Pursuant to the FEI’s delegation of its anti-doping program for human athletes to the ITA, including the independent management of results, the prosecution of the case is being handled entirely by the ITA. Given that the case is underway, there will be no further comments during the ongoing proceeding.